Stroke, Vol 19, 1404-1410, Copyright © 1988 by American Heart Association
RE Albright Jr, AH Friedman, EK Fram, OL Harbury, BA Molter, JH Skatoff, CC Harris, RE Coleman and BP Drayer
We determined regional cerebral blood flow (rCBF) using [125I]HIPDm
[N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3- propanediamin
e] and [125I]iodoantipyrine autoradiography under control and pathologic
conditions (hypercapnia [acidosis], hypocapnia [alkalosis], and disrupted
blood-brain barrier) conditions in 35 rats. In control rats, HIPDm rCBF
(indicator fractionation method, n = 5) was lower than the corresponding
IAP rCBF (diffusible indicator method, n = 4), most notably in the
infratentorial regions and subcortical nuclei. In hypercapnia, rCBF
increased by 100% and 37% in the HIPDm (n = 5) and IAP (n = 5) groups,
respectively. In hypocapnia, IAP rCBF (n = 4) decreased 34% but HIPDm rCBF
(n = 4) did not change. Following disruption of the blood-brain barrier by
intracarotid infusion of mannitol in eight rats, both radiotracers (HIPDm n
= 4, IAP n = 4) showed decreased rCBF to regions of disruption as defined
by trypan blue extravasation. Our work indicates that modeling HIPDm uptake
to quantify rCBF using the indicator fractionation method will
underestimate blood flow and that HIPDm kinetics are influenced by
compartmental pH dynamics that will limit the accuracy of this method in
quantifying rCBF in pathologic conditions.
ARTICLES
Comparison of [125I]HIPDm and [125I]iodoantipyrine in quantifying regional cerebral blood flow in rats
Department of Medicine (Neurology), Duke University Medical Center, Durham, North Carolina 27710.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |